Stock Events

Stock Events

Lotus Pharmaceuticals 

$0.003000
2
-$0.00-13.04% Thursday 13:30

Statistics

Day High
0.0032
Day Low
0.0032
52W High
0.0092
52W Low
0.0018
Volume
10,001
Avg. Volume
6,509
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

10NovExpected
Q4 2009
Q1 2010
Q3 2010
Q4 2010
Q1 2011
Q2 2011
Q3 2011
-0.13
-0
0.12
0.25
Expected EPS
N/A
Actual EPS
0.04

Financials

-Profit Margin
Unprofitable
2019
2021
2022
2023
0Revenue
-19,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. is a global healthcare company that produces pharmaceuticals competitive with Lotus Pharmaceuticals' offerings, particularly in therapeutic areas.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a direct competitor in the pharmaceutical industry, developing and marketing drugs that may overlap with Lotus Pharmaceuticals' product lines.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the pharmaceutical sector with a broad range of products that could compete across several of Lotus Pharmaceuticals' key areas.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline plc is a British multinational pharmaceutical company that competes in various therapeutic areas with Lotus Pharmaceuticals.
Novartis
NVS
Mkt Cap292.35B
Novartis AG is a Swiss multinational pharmaceutical company that produces drugs in direct competition with Lotus Pharmaceuticals, especially in the European market.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. is known for its innovative pharmaceuticals that could rival Lotus Pharmaceuticals' products, especially in specialty therapeutic areas.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb Company offers a range of prescription pharmaceuticals in areas that could compete with Lotus Pharmaceuticals' portfolio.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a French multinational pharmaceutical company that competes globally with Lotus Pharmaceuticals, particularly in vaccines and chronic disease treatments.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a Swiss multinational healthcare company that competes with Lotus Pharmaceuticals in the development and marketing of pharmaceuticals.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biopharmaceutical company that competes in areas like oncology, which may overlap with Lotus Pharmaceuticals' interests.

About

Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.
Show more...
CEO
Zhong Yi Liu
Employees
233
Country
United States
ISIN
US5457152032

Listings

OTC Link
US
LTUS

0 Comments

Share your thoughts

FAQ

What is Lotus Pharmaceuticals stock price today?▼
The current price of LTUS is $0.00 USD — it has decreased by -13.04% in the past 24 hours. Watch Lotus Pharmaceuticals stock price performance more closely on the chart.
What is Lotus Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Lotus Pharmaceuticals stocks are traded under the ticker LTUS.
Is Lotus Pharmaceuticals stock price growing?▼
LTUS stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Lotus Pharmaceuticals has showed a -64.71% decrease.
What were Lotus Pharmaceuticals earnings last quarter?▼
LTUS earnings for the last quarter are 0.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lotus Pharmaceuticals revenue for the last year?▼
Lotus Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Lotus Pharmaceuticals net income for the last year?▼
LTUS net income for the last year is -19,000 USD.
How many employees does Lotus Pharmaceuticals have?▼
As of September 04, 2026, the company has 233 employees.
In which sector is Lotus Pharmaceuticals located?▼
Lotus Pharmaceuticals operates in the Health & Wellness sector.
When did Lotus Pharmaceuticals complete a stock split?▼
The last stock split for Lotus Pharmaceuticals was on December 31, 2010 with a ratio of 1:2.
Where is Lotus Pharmaceuticals headquartered?▼
Lotus Pharmaceuticals is headquartered in Irvine, United States.